Who Owns Odontoprev Company?

Odontoprev Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Odontoprev?

Odontoprev S.A., a leading dental benefits company in Latin America, was founded in 1987 in São Paulo, Brazil. It began by serving corporate clients, aiming to improve dental care access and quality.

The company went public on December 1, 2006, on the B3 exchange under the ticker ODPV3, enabling significant expansion. Today, it serves around 9.0 million beneficiaries as of late 2024, with a market capitalization of $1.23 billion USD as of August 2025.

Who owns Odontoprev?

Odontoprev S.A. was established in 1987 by dental professionals aiming to provide structured dental benefits to corporate clients. While the specific names of the founders and their initial equity stakes are not publicly disclosed, the company's origin is rooted in their collective vision for professional and quality dental care.

Founding Vision

The company was born from a need for organized dental benefits within the corporate sector.

Early Ownership Shift

In August 1998, private equity investors acquired control of the company.

Private Equity Impact

This acquisition bolstered Odontoprev's strategic position and introduced innovative corporate governance.

Growth Milestone

By 2005, the company had expanded to serve 1 million beneficiaries.

Public Offering

An Initial Public Offering (IPO) occurred in December 2006, with shares priced at R$28.00.

Investor Exit

Private equity investors exited their holdings in April 2007 following the IPO.

The period under private equity ownership was crucial for Odontoprev's expansion, significantly increasing its membership base. This phase facilitated the company's growth and solidified its presence in the market. The successful IPO in December 2006, which raised a net R$171.411 million and a total of R$522.031 million, marked a pivotal moment. This public offering allowed for a broader distribution of Odontoprev's shares, transitioning it into a publicly traded entity and signifying the exit of its initial private equity investors. Understanding the Target Market of Odontoprev is key to appreciating its strategic development.

Key Ownership Transitions

Odontoprev's ownership structure evolved significantly from its founding to its public trading phase.

• Founded in 1987 by dental professionals.
• Control acquired by private equity in August 1998.
• Reached 1 million beneficiaries by 2005.
• Completed IPO in December 2006 at R$28.00 per share.
• Private equity investors exited in April 2007.

Odontoprev SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Odontoprev's ownership journey began with its IPO in December 2006, marking a shift from private equity to public trading. A pivotal moment arrived in 2009 with its merger with Bradesco Dental, a subsidiary of Bradesco Saúde, significantly altering its corporate structure and market position.

The evolution of Odontoprev's ownership structure highlights a strategic consolidation and expansion. Initially a publicly traded entity post-IPO, the company's trajectory was significantly influenced by its 2009 association with Bradesco Saúde. This partnership saw Bradesco Saúde acquire a substantial 43.5% stake in Odontoprev, a move that not only expanded its operational scale by adding 1.3 million lives to its existing 2.6 million members but also laid the groundwork for future integration. By 2013, Bradesco solidified its position by increasing its shareholding, thereby assuming outright control of the company. This controlling interest, held by Bradesco Saúde S.A., a part of Banco Bradesco S.A.'s broader insurance and pension arm, continues to shape Odontoprev's strategic direction and governance. Beyond this primary ownership, Odontoprev's shareholder base is diverse, comprising over 40,000 minority shareholders as of December 2024. Key institutional investors, including Sprucegrove Investment Management Ltd. and I. G. Investment Management Ltd., also maintain significant holdings, contributing to a broad public ownership profile. Further strategic alliances, such as the 2013 joint venture with Banco do Brasil (BB Seguridade) to establish Brasildental, underscore the dynamic network of stakeholders and their collective impact on market penetration and product distribution, reflecting the company's commitment to its Mission, Vision & Core Values of Odontoprev.

Key Stakeholders in Odontoprev

Bradesco Saúde S.A. is the dominant controlling shareholder, influencing the company's strategic decisions.

• Bradesco Saúde S.A. (Primary controlling shareholder)
• Banco Bradesco S.A. (Parent entity of Bradesco Saúde)
• Over 40,000 minority shareholders (as of December 2024)
• Sprucegrove Investment Management Ltd. (Major institutional investor)
• I. G. Investment Management Ltd. (Major institutional investor)
• Banco do Brasil (BB Seguridade) through the Brasildental joint venture

Odontoprev PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Odontoprev S.A. maintains a corporate governance structure aligned with Novo Mercado segment requirements, emphasizing transparency and accountability. The company's capital is solely represented by ordinary shares, each carrying one vote, ensuring a straightforward one-share-one-vote principle for all Odontoprev shareholders.

The Board of Directors plays a crucial role in shaping Odontoprev's strategic direction and overseeing its management. Board members are elected for two-year terms and can be re-elected. A significant aspect of the company's structure is that shareholders who hold at least 15% of the capital stock for a minimum of three months have the right to elect one board member. This provision allows for representation of substantial Odontoprev stakeholders. There have been no recent public reports indicating significant proxy battles or activist investor campaigns that have impacted the company's decision-making processes, suggesting a stable ownership and control environment. Understanding the composition and voting power of the board is key to understanding Odontoprev ownership.

Key Governance Aspects for Odontoprev

Odontoprev's commitment to robust corporate governance is evident in its adherence to Novo Mercado standards. This framework ensures that Odontoprev stakeholders are well-informed and that the company operates with a high degree of integrity.

• One-share-one-vote principle for all ordinary shares.
• Mandatory minimum of 20% independent directors on the Board.
• Shareholders with 15% stake can elect a board member.
• Board members serve two-year terms, eligible for re-election.
• This structure supports transparency in Odontoprev ownership.

Odontoprev Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the last three to five years, the company has actively refined its ownership and operational landscape. Key developments include the incorporation of Rede Dental in January 2021 and the acquisition of Mogidonto Planos Odontológicos Ltda. and Boutique Dental Ltda. through its subsidiary Clidec in June 2021. Further strategic moves involved increasing participation in Healthtech MaChiron in August 2022 and acquiring the remaining shares of Odontored in Mexico by October 2022. These actions illustrate a dynamic approach to expanding market presence and consolidating operations, impacting the overall Odontoprev ownership structure.

Leadership transitions and financial performance are central to understanding recent trends. On August 28, 2024, Rodrigo Bacellar Wuerkert resigned as CEO, with Elsen Carvalho assuming the role in addition to his Corporate Commercial Officer duties. Financially, the company maintains a debt-free status with low capital expenditure needs, prioritizing shareholder returns. For the second quarter of 2025, dividends of R$115 million were approved, a 35% increase from the second quarter of 2024. Since its 2006 IPO, the company has distributed over R$3.8 billion in dividends and interest on capital, yielding an average annual shareholder return of 15% in local currency. The company's commitment to its people and sustainable growth was recognized in 2024 as a Great Place to Work in Brazil and by TIME Magazine's 'World's Best Companies in Sustainable Growth 2025.' Industry analysis points to a strategic push into individual and SME plans, utilizing exclusive banking channels for market penetration, a strategy supported by alliances with major banks. This focus on expanding distribution channels is a key element of the Marketing Strategy of Odontoprev.

Leadership Transition

Elsen Carvalho took over as CEO on August 28, 2024. This change reflects ongoing strategic adjustments in management.

Financial Strength and Shareholder Returns

The company boasts zero debt and low capital expenditures. Dividends for 2Q25 increased by 35% compared to 2Q24.

Market Expansion Strategy

Focus is on individual and SME plans through banking channels. This targets underpenetrated markets.

Recognition and Growth

Named a Great Place to Work in Brazil for 2024. Also recognized in TIME Magazine's 'World's Best Companies in Sustainable Growth 2025.'

Odontoprev Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔